Gabay Avraham 4
4 · ORAMED PHARMACEUTICALS INC. · Filed Jun 21, 2024
Insider Transaction Report
Form 4
Gabay Avraham
Chief Financial Officer
Transactions
- Award
Common Stock
2024-06-21+140,040→ 0 total
Footnotes (1)
- [F1]Represents a grant of 140,040 Restricted Stock Units ("RSUs"), of which 93,360 will vest on June 18, 2026 and the remaining 46,680 will vest in four equal quarterly installments of 11,670 starting September 18, 2026. The RSUs convert into the Issuer's Common Stock on a one-for-one basis.